BioCardia (BCDA) Stock Price, News, Quotes-Moomoo

US Stock MarketDetailed Quotes

BCDA BioCardia

Watchlist

2.390
+0.060+2.58%

Close Nov 1 16:00 ET

2.409
+0.019+0.77%

Post 16:54 ET

8.37MMarket Cap-448P/E (TTM)

Full Hours

5D
Daily
Weekly
Monthly
1Q
1Y

Trade Overview

Unit: --

Capital Trend

IntradayDayWeekMonth

No Data

News

Express News | HC Wainwright & Co. Reiterates Buy on BioCardia, Maintains $25 Price Target
BenzingaOct 28 11:18 ET
BioCardia Analyst Ratings
BenzingaOct 28 11:14 ET · Ratings
Promising Outlook for BioCardia With Advancements in CardiAMP HF Program and Personalized Treatment Approach
TipRanksOct 28 10:55 ET
BioCardia Completes Last Protocol Specified Follow-up Visit in CardiAMP HF
TipRanksOct 28 09:10 ET
Express News | BioCardia Inc - Results on Track for Top Line Release in Q1 2025
ReutersOct 28 09:00 ET
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
GlobeNewswireOct 28 09:00 ET

Comments

Remember Top Line Data 1Q 2025

$BioCardia (BCDA.US)$

$BioCardia (BCDA.US)$
BioCardia Completes Phase III Randomized Double-Blind Controlled Trial of Autologous Cell Therapy for Ischemic Heart Failure
BioCardia has completed its Phase III CardiAMP HF trial, a randomized, double-blind, placebo-controlled study evaluating the CardiAMP Cell Therapy System for heart failure treatment. The trial enrolled 125 patients across 18 US hospitals, with 115 patients randomized 3:2 between treatment and control groups. The therapy, which received FDA Breakth...

1

$BioCardia (BCDA.US)$ same unregistered brokerage

$BioCardia (BCDA.US)$ 3$ offering yall

1

1

$BioCardia (BCDA.US)$ BioCardia Announces Pricing of Upsized $7.2 Million Public Offering Priced at-the-Market Under Nasdaq Rules

1

1

Read more

Analysis

Analyst Rating

No Data

Price Target

No Data

US

Overall

No Data